IndiaMTF — home
Stock

Anthem Biosciences — MTF Book

ANTHEM · Anthem Biosciences Limited
Health Technology

Daily Margin Trading Facility book for Anthem Biosciences across NSE and BSE, from 26 Sep 2025. All figures in ₹ crore, derived from exchange public disclosures.

What is Anthem Biosciences’s MTF book?

Anthem Biosciences Limited (ANTHEM) has ₹67 crore funded under Margin Trading Facility across NSE and BSE as of 23 Oct 2026 — 0.04% of India’s MTF book, ranking #524. Over 1M (the last 30 trading days) the funded value has fallen 3.3%, with the number of shares under margin down 3.6%.

Funded value
₹67 Cr
as of 23 Oct 2026
Rank in book
#524
265 days tracked
Share of book
0.04%
of the whole NSE + BSE book
Peak funded
₹79 Cr
on 11 Sep 2026
Largest single-day addition
+₹9 Cr
on 10 Aug 2026
Largest single-day unwind
−₹6 Cr
on 15 Sep 2026
Free-float market cap
₹13,100 Cr
full market cap ₹45,804 Cr · 28.6% free float · Mid cap
MTF share of free float
0.47%
1.1× the median mid cap · 0.5× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

0.06%0.21%0.37%0.52%Sep 2025Oct 2026
View as table: share of free float on margin14 months
Month-end% of free float
23 Oct 20260.466%
30 Sep 20260.463%
31 Aug 20260.406%
31 Jul 20260.232%
30 Jun 20260.283%
29 May 20260.161%
30 Apr 20260.184%
30 Mar 20260.172%
27 Feb 20260.164%
30 Jan 20260.215%
31 Dec 20250.247%
28 Nov 20250.294%
31 Oct 20250.222%
30 Sep 20250.110%

Dated events

NSE & BSE split

How ANTHEM’s funded book divides across the two exchanges, as of 23 Oct 2026.
NSE
NSE ₹65 Cr · 97.1%BSE ₹2 Cr · 2.9%

MTF vs Price

Margin-funded outstanding for ANTHEM in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹812.80
as of 23 Oct 2026
Price, 1M
−13.8%
adjusted for splits and bonuses
Delivery, 20-day avg
55.2%
of traded volume actually settled
Sessions to unwind
3
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1D−₹2−2.2%−2.2%
−17,251
+1.5%unwinding into strength
10D−₹2−2.2%−1.7%
−12,848
−6.8%unwinding as it falls
1M−₹2−3.3%−3.6%
−27,759
−15.1%unwinding as it falls
3M+₹39+137.9%+106.5%
+3,87,296
+4.5%building into strength
6M+₹42+175.2%+124.1%
+4,15,925
+9.7%building into strength
1Y+₹44+194.7%+160.0%
+4,62,187
+13.2%building into strength

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where ANTHEM has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

ANTHEM — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
23 Oct 202667−₹20.04%524
22 Oct 202668+₹00.04%520
21 Oct 202668−₹10.04%525
19 Oct 202670+₹10.04%522
16 Oct 202669+₹00.04%526
15 Oct 202669−₹00.04%528
14 Oct 202669+₹10.04%526
13 Oct 202668−₹00.04%529
12 Oct 202668−₹00.04%529
09 Oct 202668+₹00.04%527
08 Oct 202668−₹10.04%531
07 Oct 202669+₹00.04%524
06 Oct 202668+₹50.04%524
05 Oct 202664−₹10.04%554
01 Oct 202664−₹20.04%548
30 Sep 202666+₹10.04%542
29 Sep 202666+₹10.04%543
28 Sep 202665−₹40.04%548
25 Sep 202669+₹00.04%529
24 Sep 202668+₹20.04%532
23 Sep 202667−₹10.04%540
22 Sep 202668−₹50.04%532
21 Sep 202673+₹60.05%495
18 Sep 202667−₹30.04%531
17 Sep 202670+₹00.04%510
16 Sep 202670−₹30.04%507
15 Sep 202672−₹60.05%495
11 Sep 202679+₹20.05%469
10 Sep 202677+₹30.05%477
09 Sep 202674—0.05%488

ANTHEM within Health Technology

Ranked #25 of 61 funded Health Technology stocks, carrying 1.0% of that sector’s margin book. Its 0.47% of free float on margin is 0.5× the sector median of 0.90%. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector% of free floatBook, 1M
23ONESOURCEOnesource Specialty Pharma₹781.2%0.62%+73.3%
24GLANDGland Pharma₹721.1%0.30%−65.4%
25ANTHEMAnthem Biosciences₹671.0%0.47%−3.3%
26SUVENSuven Life Sciences₹641.0%2.14%+1.1%
27SUDEEPPHRMSudeep Pharma₹620.9%2.31%+16.3%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.